医学临床研究
  2025年7月20日 星期日           首 页    |    期刊简介    |    编委会    |    投稿指南    |    期刊订阅    |    广告合作    |    留言板    |    联系我们    |    English
医学临床研究  2022, Vol. 39 Issue (8): 1197-1201    DOI: 10.3969/j.issn.1671-7171.2022.08.021
  论著 本期目录 | 过刊浏览 | 高级检索 |
血清miR-21、cys C、sCD40L及sICAM-1水平与糖尿病肾病的相关性分析
贾秋利, 赵旭敏*
榆林市第一医院内分泌科,陕西 榆林 719000
Correlation Analysis of Serum Levels of miR-21, cys C, sCD40L and sICAM-1 with Diabetes Nephropathy
JIA Qiu-li, ZHAO Xu-min
Department of Endocrinology,The First Hospital of Yulin,Yulin Shaanxi 719000
全文: PDF (1229 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 【目的】探讨血清微小RNA-21(miR-21)、胱抑素C(cys C)、可溶性白细胞分化抗原CD40配体(sCD40L)及可溶性细胞间黏附因子-1(sICAM-1)水平与糖尿病肾病(DN)的相关性。【方法】选择2019年10月至2021年10月本院收治的162例2型糖尿病患者,按照尿微量白蛋白排泄率(UACR)分为A组(UACR<30 mg/24 h,单纯2型糖尿病)70例、B组(UACR 30~300 mg/24 h,早期DN)52例、C组(UACR>300 mg/24 h,DN)40例;另选择同期在本院体检的健康志愿者60例为D组。比较各组血清miR-21、cys C、sCD40L、sICAM-1水平及与各生化指标的相关性,采用受试者工作特征(ROC)曲线分析上述指标对早期DN的诊断效能。【结果】A组、B组、C组血清miR-21水平较D组明显降低(P<0.05),血清cys C、sCD40L、sICAM-1水平较D组明显升高(P<0.05);A组、B组、C组血清miR-21水平逐渐降低(P<0.05),血清cys C、sCD40L、sICAM-1水平逐渐升高(P<0.05)。血清miR-21、cys C、sCD40L、sICAM-1与糖化血红蛋白(HbA1c)、三酰甘油(TG)、低密度脂蛋白胆固醇(LDL-C)、UACR均呈正相关(P<0.05),与估算肾小球滤过率(eGFR)均呈负相关(P<0.05)。血清miR-21、cys C、sCD40L、sICAM-1对早期DN均有一定诊断效能,曲线下面积分别为0.801、0.774、0.873、0.789。【结论】miR-21、cys C、sCD40L、sICAM-1均参与DN发病过程,与病情严重程度有关,均可作为早期DN诊断的可靠标志物。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
贾秋利
赵旭敏
关键词 糖尿病肾病微RNAs/血液抑素类/血液胞间黏附分子1/血液    
Abstract:【Objective】To investigate the relationship between serum levels of microRNA-21 (miR-21), Cystatin C (cys C), soluble leukocyte differentiation antigen CD40 ligand (sCD40L) and soluble intercellular adhesion factor-1 (sICAM-1) and diabetes nephropathy (DN). 【Methods】A total of 162 patients with type 2 diabetes admitted to our hospital from October 2019 to October 2021 were selected. According to urinary microalbumin excretion rate (UACR), they were divided into group A (UACR<30 mg/24 h, simple type 2 diabetes) 70 cases, group B (UACR 30-300 mg/24 h, early DN) 52 cases, and group C (UACR >300 mg/24 h,DN) 40 cases; In addition, 60 healthy volunteers who underwent physical examination in our hospital in the same period were selected as Group D. The serum levels of miR-21, cys C, sCD40L, sICAM-1 and their correlations with various biochemical indexes were compared in each group. The diagnostic efficacy of the above indexes for early DN was analyzed by using the receiver operating characteristic (ROC) curve. 【Results】 The levels of serum miR-21 in group A, B and C were significantly lower than those in group D (P<0.05), and the levels of serum cys C, sCD40L and sICAM-1 were significantly higher than those in group D (P<0.05); The levels of serum miR-21 in group A, group B and group C gradually decreased (P<0.05), and the levels of serum cys C, sCD40L and sICAM-1 gradually increased (P<0.05). Serum miR-21, cys C, sCD40L and sICAM-1 were positively correlated with HbA1c, TG, LDL-C and UACR (P<0.05), and negatively correlated with estimated glomerular filtration rate (EGFR) (P<0.05). Serum miR-21,cys C,sCD40L and sICAM-1 had certain diagnostic efficacy for early DN, and the area under the curve was 0.801, 0.774, 0.873 and 0.789, respectively.【Conclusion】miR-21, cys C, sCD40L and sICAM-1 are all involved in the pathogenesis of DN and are related to the severity of the disease. They can be used as reliable markers for early diagnosis of DN.
Key wordsDiabetic Nephropathies    MicroRNAs/BL    Chalones/BL    Intercellular Adhesion Molecule-1/BL
收稿日期: 2022-01-20     
中图分类号:  R587.24  
通讯作者: *E-mail:zxmhu58@126.com   
引用本文:   
贾秋利, 赵旭敏. 血清miR-21、cys C、sCD40L及sICAM-1水平与糖尿病肾病的相关性分析[J]. 医学临床研究, 2022, 39(8): 1197-1201.
JIA Qiu-li, ZHAO Xu-min. Correlation Analysis of Serum Levels of miR-21, cys C, sCD40L and sICAM-1 with Diabetes Nephropathy. JOURNAL OF CLINICAL RESEARCH, 2022, 39(8): 1197-1201.
链接本文:  
http://journal07.magtech.org.cn/yxlcyj/CN/10.3969/j.issn.1671-7171.2022.08.021     或     http://journal07.magtech.org.cn/yxlcyj/CN/Y2022/V39/I8/1197
版权所有 © 2013 医学临床研究杂志社  湘ICP备13012052号-1
办公地址:湖南省长沙市芙蓉区新军路43号煤炭大院主办公楼6楼621、623、632、636室 邮编:410011 电话(传真):0731-84824007 E-mail:jcr_cs.hn@vip.163.com
技术支持:北京玛格泰克科技发展有限公司 技术支持:support@magtech.com.cn